Corticosteroids increase protein breakdown and loss in newly diagnosed pediatric crohn disease

Steven Steiner, Joshua D. Noe, Scott Denne

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Children with Crohn disease have altered growth and body composition. Previous studies have demonstrated decreased protein breakdown after either corticosteroid or anti-TNF-α therapy. The aim of this study was to evaluate whole body protein metabolism during corticosteroid therapy in children with newly diagnosed Crohn disease. Children with suspected Crohn disease and children with abdominal symptoms not consistent with Crohn disease underwent outpatient metabolic assessment. Patients diagnosed with Crohn disease and prescribed corticosteroid therapy returned in 2 wk for repeat metabolic assessment. Using the stable isotopes [d5] phenylalanine, [1- 13C] leucine, and [ 15N2] urea, protein kinetics were determined in the fasting state. Thirty-one children (18 controls and 13 newly diagnosed with Crohn disease) completed the study. There were no significant differences in protein breakdown or loss between patients with Crohn disease at diagnosis and controls. After corticosteroid therapy in patients with Crohn disease, the rates of appearance of phenylalanine (32%) and leucine (26%) increased significantly, reflecting increased protein breakdown, and the rate of appearance of urea also increased significantly (273%), reflecting increased protein loss. Whole body protein breakdown and loss increased significantly after 2 wk of corticosteroid therapy in children with newly diagnosed Crohn disease, which may have profound effects on body composition.

Original languageEnglish
Pages (from-to)484-488
Number of pages5
JournalPediatric Research
Volume70
Issue number5
DOIs
StatePublished - Nov 2011

Fingerprint

Crohn Disease
Adrenal Cortex Hormones
Proteins
Body Composition
Phenylalanine
Leucine
Urea
Therapeutics
Pediatric Crohn's disease
Isotopes
Fasting
Outpatients
Growth

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Corticosteroids increase protein breakdown and loss in newly diagnosed pediatric crohn disease. / Steiner, Steven; Noe, Joshua D.; Denne, Scott.

In: Pediatric Research, Vol. 70, No. 5, 11.2011, p. 484-488.

Research output: Contribution to journalArticle

@article{94d583ea9f9b43dfbcfce01d5ef70114,
title = "Corticosteroids increase protein breakdown and loss in newly diagnosed pediatric crohn disease",
abstract = "Children with Crohn disease have altered growth and body composition. Previous studies have demonstrated decreased protein breakdown after either corticosteroid or anti-TNF-α therapy. The aim of this study was to evaluate whole body protein metabolism during corticosteroid therapy in children with newly diagnosed Crohn disease. Children with suspected Crohn disease and children with abdominal symptoms not consistent with Crohn disease underwent outpatient metabolic assessment. Patients diagnosed with Crohn disease and prescribed corticosteroid therapy returned in 2 wk for repeat metabolic assessment. Using the stable isotopes [d5] phenylalanine, [1- 13C] leucine, and [ 15N2] urea, protein kinetics were determined in the fasting state. Thirty-one children (18 controls and 13 newly diagnosed with Crohn disease) completed the study. There were no significant differences in protein breakdown or loss between patients with Crohn disease at diagnosis and controls. After corticosteroid therapy in patients with Crohn disease, the rates of appearance of phenylalanine (32{\%}) and leucine (26{\%}) increased significantly, reflecting increased protein breakdown, and the rate of appearance of urea also increased significantly (273{\%}), reflecting increased protein loss. Whole body protein breakdown and loss increased significantly after 2 wk of corticosteroid therapy in children with newly diagnosed Crohn disease, which may have profound effects on body composition.",
author = "Steven Steiner and Noe, {Joshua D.} and Scott Denne",
year = "2011",
month = "11",
doi = "10.1203/PDR.0b013e31822f5886",
language = "English",
volume = "70",
pages = "484--488",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Corticosteroids increase protein breakdown and loss in newly diagnosed pediatric crohn disease

AU - Steiner, Steven

AU - Noe, Joshua D.

AU - Denne, Scott

PY - 2011/11

Y1 - 2011/11

N2 - Children with Crohn disease have altered growth and body composition. Previous studies have demonstrated decreased protein breakdown after either corticosteroid or anti-TNF-α therapy. The aim of this study was to evaluate whole body protein metabolism during corticosteroid therapy in children with newly diagnosed Crohn disease. Children with suspected Crohn disease and children with abdominal symptoms not consistent with Crohn disease underwent outpatient metabolic assessment. Patients diagnosed with Crohn disease and prescribed corticosteroid therapy returned in 2 wk for repeat metabolic assessment. Using the stable isotopes [d5] phenylalanine, [1- 13C] leucine, and [ 15N2] urea, protein kinetics were determined in the fasting state. Thirty-one children (18 controls and 13 newly diagnosed with Crohn disease) completed the study. There were no significant differences in protein breakdown or loss between patients with Crohn disease at diagnosis and controls. After corticosteroid therapy in patients with Crohn disease, the rates of appearance of phenylalanine (32%) and leucine (26%) increased significantly, reflecting increased protein breakdown, and the rate of appearance of urea also increased significantly (273%), reflecting increased protein loss. Whole body protein breakdown and loss increased significantly after 2 wk of corticosteroid therapy in children with newly diagnosed Crohn disease, which may have profound effects on body composition.

AB - Children with Crohn disease have altered growth and body composition. Previous studies have demonstrated decreased protein breakdown after either corticosteroid or anti-TNF-α therapy. The aim of this study was to evaluate whole body protein metabolism during corticosteroid therapy in children with newly diagnosed Crohn disease. Children with suspected Crohn disease and children with abdominal symptoms not consistent with Crohn disease underwent outpatient metabolic assessment. Patients diagnosed with Crohn disease and prescribed corticosteroid therapy returned in 2 wk for repeat metabolic assessment. Using the stable isotopes [d5] phenylalanine, [1- 13C] leucine, and [ 15N2] urea, protein kinetics were determined in the fasting state. Thirty-one children (18 controls and 13 newly diagnosed with Crohn disease) completed the study. There were no significant differences in protein breakdown or loss between patients with Crohn disease at diagnosis and controls. After corticosteroid therapy in patients with Crohn disease, the rates of appearance of phenylalanine (32%) and leucine (26%) increased significantly, reflecting increased protein breakdown, and the rate of appearance of urea also increased significantly (273%), reflecting increased protein loss. Whole body protein breakdown and loss increased significantly after 2 wk of corticosteroid therapy in children with newly diagnosed Crohn disease, which may have profound effects on body composition.

UR - http://www.scopus.com/inward/record.url?scp=80053908068&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053908068&partnerID=8YFLogxK

U2 - 10.1203/PDR.0b013e31822f5886

DO - 10.1203/PDR.0b013e31822f5886

M3 - Article

C2 - 21814156

AN - SCOPUS:80053908068

VL - 70

SP - 484

EP - 488

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 5

ER -